IMAX Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMAX research report →
Range $41 – $60
Price Chart
About the company
IMAX Corporation operates as a global entertainment technology firm, specializing in delivering advanced cinematic experiences. It achieves this by leveraging its proprietary software, unique theater designs, intellectual property, and specialized equipment. A core offering is IMAX Digital Re-Mastering (DMR), a patented process that dramatically improves the resolution, visual fidelity, and audio quality of motion picture films for their presentation on IMAX screens.
- CEO
- Richard Lewis Gelfond
- IPO
- 1994
- Employees
- 679
- HQ
- Mississauga, ON, CA
Get TickerSpark's AI analysis on IMAX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.91B
- P/E
- 70.86
- Fwd P/E
- 29.96
- PEG
- 3.09
- P/S
- 7.00
- P/B
- 8.21
- EV/EBITDA
- 23.34
- Div Yield
- 0.00%
- Gross Margin
- 59.14%
- Op Margin
- 22.13%
- Net Margin
- 9.84%
- ROE
- 11.87%
- ROIC
- 9.34%
Latest fiscal year · YoY change
- Revenue
- $410.21M+16.5%
- Gross Profit
- $237.57M+24.9%
- Op Income
- $95.60M
- Net Income
- $34.88M+33.8%
- EPS
- $0.65+32.7%
- OCF Growth
- +79.4%
- FCF Growth
- +301.4%
- 52W High
- $54.50
- 52W Low
- $25.56
- 50D MA
- $44.20
- 200D MA
- $38.67
- Beta
- 0.39
- RSI (14)
- 65
- Avg Volume
- 1.32M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
IMAX posted strong Q2 2026 results and said Christopher Nolan’s The Odyssey is already a transformational box-office and brand event that is exceeding expectations.· July 23, 2026
- Q2 revenue was $103 million, up 12% year over year; adjusted EPS was $0.43, up 65%; adjusted EBITDA was $48 million at a 46.6% margin.
- Gross profit was $63 million, up 17% year over year, with a 61% margin; technology products and services margin improved to 60%.
- The Odyssey delivered IMAX’s biggest global opening weekend ever on a like-for-like basis at $52 million and is driving record weekday holds, presales, and occupancy.
- System demand remained solid: 38 installations in Q2, 36 signings in the quarter, and 62 signings year to date.
- Management reiterated confidence in a record $1.4 billion global box office year and said full-year guidance remains intact, including mid-40s adjusted EBITDA margin.
- Cash flow was strong and capital was returned via $13.7 million of share repurchases, while the company ended Q2 with $160 million in cash and $292 million in debt.
IMAX reported Q2 2026 revenue of $103 million, up 12% from $92 million a year ago. Adjusted EPS was $0.43, up 65% year over year, and adjusted EBITDA was $48 million with a 46.6% margin, up 400 basis points from 42.6%. Gross profit was $63 million, up 17% year over year, with a 61% margin; Content Solutions gross profit was $22 million, roughly flat, and Technology Products and Services revenue was $65 million, up 16%, with a 60% gross margin, up 600 basis points. For the first half, cash from operations was a $36 million inflow versus $30 million a year ago. Management said it remains on track for a record $1.4 billion in global box office for the full year, maintained its 2026 EBITDA guidance, and reiterated a full-year adjusted EBITDA margin target in the mid-40s. Natasha Fernandes also said the install guidance range remains $160 million to $175 million.
Rich Gelfond framed The Odyssey as a defining IMAX moment, saying the film is the purest expression yet of the company’s value proposition and is already producing results beyond expectations. He repeatedly emphasized that IMAX is becoming the center of the cultural conversation, with record presales, strong weekday holds, and sustained fan demand for 70-millimeter showings. His tone was highly confident and upbeat, but he also pointed to a broader slate beyond Odyssey, including Dune Part Three, Spider-Man, Narnia and other IMAX-centric titles that he believes support a strong pipeline into 2027.
Natasha Fernandes highlighted broad-based financial strength: revenue up 12%, adjusted EBITDA of $48 million, EBITDA margin of 46.6%, gross profit of $63 million, and adjusted EPS of $0.43. She said operating expenditures excluding stock comp were $29 million, down from $30 million a year ago, reflecting cost discipline and modest R&D growth, and noted that first-half operating cash flow was $36 million even after $10 million of lease incentive payments. She also said IMAX deployed $13.7 million to share repurchases in Q2, ended June 30 with $160 million of cash and $292 million of debt, and had net leverage of 0.7x.
Analysts focused on what Odyssey’s success means for future growth, 70-millimeter capacity, pricing, China, system sales mix, cash conversion and merchandising. Management said it is already briefing filmmakers and studios on how to lean into IMAX marketing, that 70-millimeter expansion is possible but economically finite, and that the current exhibitor/studio pricing model is working well though IMAX sees room for higher ticket prices on film. On China, Rich said first-half performance was disappointing but recent trends are improving, with Spider-Man presales described as strong and a cautiously optimistic view on Odyssey and other titles; Natasha said margin strength reflected box office above the level where incrementality usually kicks in, plus higher take from lease incentives. They also said merchandising is a meaningful opportunity but this year was mainly about proving the model, while the China in-vehicle entertainment partnership requires little or no R&D or capex from IMAX.
The call suggested IMAX is benefiting from a rare cultural event in The Odyssey, which is driving record openings, holds, occupancy and presales while reinforcing the company’s premium brand. Management also sees a strong second-half slate, continued exhibitor demand, improving China trends, and expanding optionality from merchandising and other new businesses.
Management acknowledged that 70-millimeter expansion is constrained by economics and that the film business is inherently finite in how many locations can support it. China’s first half was described as disappointing, merchandising is still early and underdeveloped, and the company said some release-date competition may not be optimized, which could limit box office overlap and execution.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 76.0%
- Shares Outstanding
- 54.84M
- Float Shares
- 41.69M
of shares held by institutions
266 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for IMAX, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Orbis Allan Gray Ltd | 5.15M | ▼ 2.17K |
| Macquarie Management Holdings, Inc. | 2.94M | ▼ 767.55K |
| Blackrock, Inc. | 2.91M | ▲ 284.60K |
| Westfield Capital Management Co LP | 2.65M | ▲ 315.24K |
| Congress Asset Management Co /Ma | 2.54M | ▲ 1.03M |
| Driehaus Capital Management LLC | 2.34M | ▲ 688.76K |
| Fmr LLC | 2.32M | ▼ 794.97K |
| Ameriprise Financial Inc | 1.77M | ▲ 442.70K |
| Goldman Sachs Group Inc | 1.66M | ▲ 785.97K |
| Jpmorgan Chase & Co | 1.45M | ▲ 480.06K |
| Price T Rowe Associates Inc | 1.45M | ▲ 493.04K |
| Royce & Associates LP | 1.34M | ▲ 96.99K |
Held by 201 ETFs
Biggest fund positions in IMAX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 6, 26 | Zlatar Jose Aleksandr | sell | 500 |
| Jun 11, 26 | Throop Darren D | other | 4,611 |
| Jun 11, 26 | Throop Darren D | other | 2,474 |
| Jun 11, 26 | Throop Darren D | other | 4,611 |
| Jun 11, 26 | Throop Darren D | other | 4,611 |
| Jun 11, 26 | MacMillan Michael | other | 3,390 |
| Jun 11, 26 | MacMillan Michael | other | 1,849 |
| Jun 11, 26 | MacMillan Michael | other | 3,390 |
| Jun 11, 26 | MacMillan Michael | other | 3,390 |
| Jun 11, 26 | Demirian Eric A | other | 3,390 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IMAX coverage
Recent articles, reports, and earnings notes.
Want a deeper read on IMAX?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
“The Odyssey” Demand Drives IMAX Shares Higher
fxempire.com · Aug 18
Imax (IMAX) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com · Aug 17
Why IMAX Stock Rallied on Monday
fool.com · Aug 10
Why IMAX Stock Soared on Monday
fool.com · Aug 3
'The Odyssey' fuels Imax stock to all-time high. CEO calls momentum a 'flywheel'
cnbc.com · Aug 3
IMAX Stock Reaches All-Time High As CEO Says ‘The Odyssey' Demand ‘Continues To Defy Gravity'
forbes.com · Aug 3
‘The Odyssey' still has people clamoring for Imax showings—even at 6 in the morning
fastcompany.com · Aug 3
Sony Pictures' Spider-Man: Brand New Day to Expand in IMAX® Across North America Beginning August 6
businesswire.com · Aug 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
